View in EDS HTML Full Text PDF Full Text

Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy.

Saved in:
Bibliographic Details
Title: Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy.
Authors: Angulo JC; Clinical Department, Faculty of Medical Sciences, European University of Madrid, 28905 Getafe, Spain., Larrinaga G; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Lecumberri D; Department of Urology, Urduliz University Hospital, 48610 Urduliz, Spain., Iturregui AM; Department of Urology, Urduliz University Hospital, 48610 Urduliz, Spain., Solano-Iturri JD; Pathology Department, Cruces University Hospital, 48903 Barakaldo, Spain., Lawrie CH; Molecular Oncology Group, Biogipuzkoa Health Research Institute, 20014 San Sebastián, Spain.; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain.; Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK.; Sino-Swiss Institute of Advanced Technology (SSIAT), Shanghai University, Shanghai 201800, China., Armesto M; Molecular Oncology Group, Biogipuzkoa Health Research Institute, 20014 San Sebastián, Spain., Dorado JF; PeRTICA Statistical Solutions, Plaza de la Constitución, 2, 28943 Fuenlabrada, Spain., Nunes-Xavier CE; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway., Pulido R; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain., Manini C; Pathology Department, S. Giovanni Bosco Hospital, 10154 Turin, Italy., López JI; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.
Source: Cancers [Cancers (Basel)] 2024 Aug 07; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 07.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39199559
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Angulo+JC%22">Angulo JC</searchLink>; Clinical Department, Faculty of Medical Sciences, European University of Madrid, 28905 Getafe, Spain.<br /><searchLink fieldCode="AU" term="%22Larrinaga+G%22">Larrinaga G</searchLink>; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.<br /><searchLink fieldCode="AU" term="%22Lecumberri+D%22">Lecumberri D</searchLink>; Department of Urology, Urduliz University Hospital, 48610 Urduliz, Spain.<br /><searchLink fieldCode="AU" term="%22Iturregui+AM%22">Iturregui AM</searchLink>; Department of Urology, Urduliz University Hospital, 48610 Urduliz, Spain.<br /><searchLink fieldCode="AU" term="%22Solano-Iturri+JD%22">Solano-Iturri JD</searchLink>; Pathology Department, Cruces University Hospital, 48903 Barakaldo, Spain.<br /><searchLink fieldCode="AU" term="%22Lawrie+CH%22">Lawrie CH</searchLink>; Molecular Oncology Group, Biogipuzkoa Health Research Institute, 20014 San Sebastián, Spain.; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain.; Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK.; Sino-Swiss Institute of Advanced Technology (SSIAT), Shanghai University, Shanghai 201800, China.<br /><searchLink fieldCode="AU" term="%22Armesto+M%22">Armesto M</searchLink>; Molecular Oncology Group, Biogipuzkoa Health Research Institute, 20014 San Sebastián, Spain.<br /><searchLink fieldCode="AU" term="%22Dorado+JF%22">Dorado JF</searchLink>; PeRTICA Statistical Solutions, Plaza de la Constitución, 2, 28943 Fuenlabrada, Spain.<br /><searchLink fieldCode="AU" term="%22Nunes-Xavier+CE%22">Nunes-Xavier CE</searchLink>; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Pulido+R%22">Pulido R</searchLink>; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain.<br /><searchLink fieldCode="AU" term="%22Manini+C%22">Manini C</searchLink>; Pathology Department, S. Giovanni Bosco Hospital, 10154 Turin, Italy.<br /><searchLink fieldCode="AU" term="%22López+JI%22">López JI</searchLink>; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2024 Aug 07; Vol. 16 (16). <i>Date of Electronic Publication: </i>2024 Aug 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39199559
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers16162786
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Angulo JC
      – PersonEntity:
          Name:
            NameFull: Larrinaga G
      – PersonEntity:
          Name:
            NameFull: Lecumberri D
      – PersonEntity:
          Name:
            NameFull: Iturregui AM
      – PersonEntity:
          Name:
            NameFull: Solano-Iturri JD
      – PersonEntity:
          Name:
            NameFull: Lawrie CH
      – PersonEntity:
          Name:
            NameFull: Armesto M
      – PersonEntity:
          Name:
            NameFull: Dorado JF
      – PersonEntity:
          Name:
            NameFull: Nunes-Xavier CE
      – PersonEntity:
          Name:
            NameFull: Pulido R
      – PersonEntity:
          Name:
            NameFull: Manini C
      – PersonEntity:
          Name:
            NameFull: López JI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 08
              Text: 2024 Aug 07
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1